Tandem Diabetes Care (TNDM) Other Operating Expenses (2013 - 2025)
Tandem Diabetes Care posted quarterly Other Operating Expenses of $75.2 million for Q1 2025, up 7521800.0% on a QoQ basis from -$1000.0 in Q4 2024.
Tandem Diabetes Care (TNDM) has 8 years of Other Operating Expenses data on file, last reported at $75.2 million in Q1 2025.
- For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to $75.2 million; the trailing twelve-month figure through Dec 2025 stood at $75.2 million (up 7521800.0% YoY), and the FY2025 full-year result was $75.2 million, changed N/A from the prior year.
- Other Operating Expenses for Q1 2025 stood at $75.2 million, up from -$1000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $78.8 million in Q1 2023 and bottomed at -$1000.0 in Q4 2024.
- The 4-year median for Other Operating Expenses is $31.0 million (2022), against an average of $37.0 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 75.22 Mn |
| Dec 31, 2024 | -1,000.00 |
| Mar 31, 2023 | 78.75 Mn |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 31.02 Mn |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Dec 31, 2013 | 2.00 |
| Sep 30, 2013 | -379.00 |
| Jun 30, 2013 | -70.00 |
| Mar 31, 2013 | 446.00 |